Campaign for Access to Essential Medicines, by Medecins Sans Frontieres

Untangling the Web of Antiretroviral Price Reductions

  • Background: Access to ARVs
  • Drug Profiles
  • Archive
  • News

Drug Prices & Patent Status

Browse By:

  • Drug
  • Company
  • Therapeutic Class

By Therapeutic Class

  • Entry Inhibitor
  • Nucleoside & Nucleotide Reverse Transcriptase Inhibitors (NRTI & NtRTI)
  • Fusion Inhibitor
  • Protease Inhibitors (PI)
  • Integrase Inhibitor
  • Fixed-Dose Combinations (FDC) and Co-Packs
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)

Home

  • Background: Access to ARVs
  • Drug Profiles
  • Archive
  • News
MSF Campaign for Access to Essential Medicines  |  Rue de Lausanne 78 – Mailbox 116 – CH-1211 Genève 21
Phone:  +41 22 849 84 05  |  Fax:  +41 22 849 84 04  |  Email: